Aa
Aa
A
A
A
Close
Avatar universal

Encouraging results for pepcid trial today

88 patients took it
1 Responses
Sort by: Helpful Oldest Newest
Avatar universal
"Compared to the rest of the patients, those who received famotidine (the active ingredient in Pepcid) had a greater than 2-fold decreased risk of either dying or being intubated," according to a statement by authors of the study at Columbia University Irving Medical Center.

You can read about the trial here. https://www.cnn.com/2020/05/09/health/famotidine-covid-19-correlation-study/index.html

The article doesn't mention that the idea to do the trial came from Chinese doctors in Wuhan who had noticed that poor people with heartburn (Pepcid is cheap so they often choose it) fared better than richer ones who had heartburn (they tend to take more expensive medication rather than Pepcid). So this trial was done in the US to see if famotidine had any effect.
Helpful - 0
Have an Answer?

You are reading content posted in the COVID19 Community

Didn't find the answer you were looking for?
Ask a question
Popular Resources
Learn more with our FAQ on Ebola.
A list of national and international resources and hotlines to help connect you to needed health and medical services.
Herpes sores blister, then burst, scab and heal.
Herpes spreads by oral, vaginal and anal sex.
STIs are the most common cause of genital sores.
Condoms are the most effective way to prevent HIV and STDs.